ALPHACENTRIC ADVISORS LLC
Q3 2026 Form 13-F
SAN JUAN, PUERTO RICO
CIK 0001913464
· CRD 170679
· SEC-registered investment adviser
$112.6M Reported Value Total
ALPHACENTRIC ADVISORS LLC reports 6 total accounts under management (AUM). There are 6 discretionary accounts valued at $433,084,612, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Source: Form ADV filed 2026-06-02
Reported value
$112.6M
Quarter over quarter
-6.0%
Holdings
245
Top-10 concentration
23.4%
Key People
Form ADV owners & control persons
David Scott Miller
MEMBER
Jerry John Szilagyi
MANAGING MEMBER
Michael Thomas Schoonover
MEMBER
Filing Navigation
13F Metrics
Loading 13F Metrics
Q3 2026 13F record
Q3 2026 13F filing summary
| Period of report | September 30, 2026 |
|---|---|
| Filed | November 03, 2026 |
| Form | 13F-HR |
| Reported value | $112.6M |
| Positions | 245 |
| Change in reported value | -4.6% |
| New positions | 34 |
| Exited positions | 48 |
| Position turnover | 28.0% |
| Top-10 concentration | 23.4% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2026 13F
Filed Nov 3, 2026
|
245 | $112.6M |
|
Q2 2026 13F
Filed Jul 24, 2026
|
259 | $118.0M |
|
Q1 2026 13F
Filed May 7, 2026
|
252 | $100.1M |
|
Q4 2025 13F
Filed Feb 12, 2026
|
249 | $100.3M |
|
Q4 2024 13F
Filed Jan 31, 2025
|
209 | $100.2M |
|
Q3 2024 13F
Filed Oct 30, 2024
|
230 | $134.5M |
|
Q2 2024 13F
Filed Jul 25, 2024
|
217 | $135.8M |
|
Q1 2024 13F
Filed Apr 24, 2024
|
228 | $165.8M |
|
Q4 2023 13F
Filed Feb 14, 2024
|
216 | $149.0M |
|
Q3 2023 13F
Filed Nov 13, 2023
|
234 | $176.3M |
|
Q2 2023 13F
Filed Aug 8, 2023
|
231 | $180.2M |
|
Q1 2023 13F
Filed May 12, 2023
|
209 | $144.9M |
|
Q4 2022 13F
Filed Feb 7, 2023
|
165 | $101.2M |
|
Q3 2022 13F
Filed Nov 8, 2022
|
184 | $97.4M |
|
Q4 2021 13F
Filed Feb 25, 2022
|
220 | $343.1M |
6 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q3 2026
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | SHY ISHARES TR | $5.4M | 4.76% |
| 2 | GILD GILEAD SCIENCES INC | $3.2M | 2.82% |
| 3 | IWD ISHARES TR | $3.0M | 2.65% |
| 4 | RPV INVESCO EXCHANGE TRADED FD T | $2.9M | 2.59% |
| 5 | VRTX VERTEX PHARMACEUTICALS INC | $2.7M | 2.37% |
| 6 | INVH INVITATION HOMES INC | $1.9M | 1.71% |
| 7 | AZN ASTRAZENECA PLC | $1.9M | 1.7% |
| 8 | ROIV ROIVANT SCIENCES LTD | $1.8M | 1.64% |
| 9 | INCY INCYTE CORP | $1.8M | 1.63% |
| 10 | ARGX ARGENX SE | $1.8M | 1.57% |
| 11 | NBIX NEUROCRINE BIOSCIENCES INC | $1.5M | 1.29% |
| 12 | INSM INSMED INC | $1.4M | 1.24% |
| 13 | EEFT EURONET WORLDWIDE INC | $1.4M | 1.2% |
| 14 | PTGX PROTAGONIST THERAPEUTICS INC | $1.4M | 1.2% |
| 15 | PINE ALPINE INCOME PPTY TR INC | $1.3M | 1.16% |
| 16 | BLDR BUILDERS FIRSTSOURCE INC | $1.3M | 1.14% |
| 17 | AXSM AXSOME THERAPEUTICS INC. | $1.2M | 1.11% |
| 18 | JAZZ JAZZ PHARMACEUTICALS PLC | $1.1M | 0.96% |
| 19 | HALO HALOZYME THERAPEUTICS INC | $1.1M | 0.96% |
| 20 | ASND ASCENDIS PHARMA A/S | $1.1M | 0.95% |
Values as reported on the Q3 2026 Form 13F. Every position is in the holdings table below.